/REDW.ST
REDW.ST Stock - Redwood Pharma AB
Healthcare|BiotechnologySTO
$1.19+0.00%
+$0.00 (+0.00%) • Jul 26
62
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.30
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.30
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for REDW.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.17 – $1.20
TARGET (TP)$1.36
STOP LOSS$1.09
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.41
52W High$5.22
52W Low$0.03
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-720.277 | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-13,508,833 | $-13,048,279 | $-20,480,000 | $-14,522,693 | $-15,512,000 |
| Net Income | $-14,184,581 | $-13,039,847 | $-20,841,000 | $-14,525,206 | $-16,004,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-5.35 | $-28.31 | $-31.97 | $-28.88 | $-32.41 |
Company Overview
Redwood Pharma AB engages in the development of ophthalmic pharmaceutical therapies for unmet market needs. The company's lead development product is RP101, an eye drop that treats severe chronic dry eye disease in post-menopausal women. It uses IntelliGel, a supramolecular smart drug delivery system for development of topical formulation for ophthalmic uses, as well as for administration to the front of the eye. Redwood Pharma AB is based in Stockholm, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
REDW.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-1.06
Q1 2024
EPS Surprise History
Q2 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Q1 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Jun 27, 2025 | — | — | — | — |
Q2 2024 | Jun 27, 2024 | — | — | — | — |
Q1 2024 | Mar 31, 2024 | — | $-1.06 | — | — |
Q4 2023 | Dec 30, 2023 | — | $-1000.00 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-3.00 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-3.46 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-2.86 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-4.66 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.05 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-3.93 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-2.46 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-5.42 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.10 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-8.82 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-5.97 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.28 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.05 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-6.23 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-7.78 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.29 | — | — |
Latest News
Loading news...
Frequently Asked Questions about REDW.ST
What is REDW.ST's current stock price?
Redwood Pharma AB (REDW.ST) is currently trading at $1.19 per share. The stock has moved +0.00% today.
What is the analyst price target for REDW.ST?
No analyst price targets are currently available for this stock.
What sector is Redwood Pharma AB in?
Redwood Pharma AB operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the STO exchange.
What is REDW.ST's market cap?
Redwood Pharma AB has a market capitalization of $0.00 billion, making it a small-cap company.
Does REDW.ST pay dividends?
No, Redwood Pharma AB does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorASAP.ST
Asarina Pharma AB (publ)
$0.03
Mkt Cap: $0.0B
BIOS.ST
Bioservo Technologies AB (publ)
$0.02
Mkt Cap: $0.0B
BONZUN.ST
Bonzun AB (publ)
$0.01
Mkt Cap: $0.0B
CLINE-B.ST
Cline Scientific AB (publ)
$0.07
Mkt Cap: $0.0B
CYXO.ST
Cyxone AB (publ)
$0.02
Mkt Cap: $0.0B
DEAR.ST
Duearity AB (publ)
$0.02
Mkt Cap: $0.0B
SCOL.ST
Scandion Oncology A/S
$0.00
Mkt Cap: $0.0B
ZICC.ST
Ziccum AB (publ)
$0.25
Mkt Cap: $0.0B
Explore stocks similar to REDW.ST for comparison